Aflac Inc (AFL)
Financials · Life & Health Insurance · US stock · S&P 500 component
$119.97
▲ +1.92 (1.63%)
Fair valueFair
$111 −7.8% to fair value
$55fair band $77–$144$166
Day's range
$117.58 – $119.97
52-week range
$103.27 – $129.57
About Aflac Inc
Aflac provides supplemental health and life insurance, including cover for cancer, accidents, hospital stays and disability, that pays cash benefits directly to policyholders. It operates in the United States, where policies are largely offered through employers at the workplace, and in Japan, where it has a large presence. The two businesses are organised as Aflac Japan and Aflac U.S.
Aflac earns money from premiums paid by policyholders and from investment income on the assets backing its policies. Revenue is $18.1 billion over the last twelve months, but revenue growth over three years is -3.6% a year. The operating margin is 33.3%, and the business earns a profit of 21% on the capital invested in it. The dividend yield is 2.0%. On the site's X-Ray Score it receives 38 out of 100.
Written with AI from public information and the filing figures on this page, then checked automatically for unsupported numbers. It can contain mistakes: read the company's own filings below before relying on it.
Price chart
52-wk range $103.27 – $129.57Volume 1,908,300Daily, split-adjusted
Vitals
Market cap$60.7B
52-week range$103.27 – $129.57
Volume (last day)1,908,300
P/E (TTM)12.9
EBIT / EV yield11.0%
Free-cash-flow yield–
Dividend yield2.0%
Revenue (TTM)$18.1B
Net income (TTM)$4.9B
Operating margin33.3%
Return on capital20.9%
Debt incl. leasesData missing
Cash & securities$6.1B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies like Apple). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
$111
Fair
−7.8% to fair value
Equal blend of three models: peer multiples, a fundamentals-adjusted multiple (growth, ROIC and margin) and a 10-year DCF scaled to the market's average. Earnings-power value (no growth) is a floor and not part of the blend. Model uncertainty is Medium, so the safety margin is 30%.
Price $120
Undervalued < $77Fair $77 – $144Overvalued > $144
Excess-return (bank)
$86
A model estimate, not a price target or recommendation. Inputs: risk-free 5.09%, equity risk premium 4.23% (Damodaran). How it works.
What this means
Weak business, fairly priced
The price sits inside our fair-value band. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Financials peers. Open a lens to see the numbers behind it.
Valuation
Fair
55/100
Priced about in line with its sector.
See the numbers →
EBIT / EV yield11.0%
Fair value vs price0.9×
Growth
Weak
8/100
Growing slower than most of its sector.
See the numbers →
Revenue growth (3y)-3.6%
EPS growth (3y)-0.5%
Growth consistency40%
Profitability
Fair
50/100
Returns on capital are typical for its sector.
See the numbers →
Return on invested capital20.9%
Operating margin33.3%
Financial health
Weak
24/100
Balance sheet is more stretched than most peers.
See the numbers →
Piotroski F-Score4 / 9
Interest cover25.3×
Dividends
Fair
50/100
Dividend is typical for its sector.
See the numbers →
Dividend yield2.0%
Dividend growth7.0%
Quarterly results: last 6 quarters
-37.5%
Mar '25
-19.0%
Jun '25
+60.7%
Sep '25
-9.9%
Dec '25
+27.9%
Mar '26
-1.0%
Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $4.1B, diluted EPS $1.63.
Compare with peers
PFH Prudential Financial I...55 GL Globe Life Inc.53 MET Metlife Inc51 PFG Principal Financial Gr...34Other Life & Health Insurance companies by X-Ray Score.
Fundamentals checklist
● 0 Good · ● 5 Average · ● 5 BadCash quality
Earnings backed by cashBad
Risk models
Piotroski F-ScoreBad
Growth
EPS growth (3y)Bad
Revenue growth (3y)Bad
Growth consistencyBad
Balance sheet
Interest coverAverage
Valuation
Fair value vs priceAverage
EBIT / EV yieldAverage
Profitability
Return on invested capitalAverage
Operating marginAverage
Each check is graded against the company's sector, not a fixed number. Checklist score 35/100.
Financials
| FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Revenue | $21.6B | $19.1B | $18.7B | $18.9B | $17.2B |
| Operating income | $4.9B | $4.2B | $5.5B | $6.6B | $4.8B |
| Net income | $4.2B | $4.4B | $4.7B | $5.4B | $3.6B |
| Operating cash flow | $5.1B | $3.9B | $3.2B | $2.7B | $2.6B |
| Operating margin | 22.9% | 21.7% | 29.2% | 34.9% | 27.7% |
| Free cash flow | – | – | – | – | – |
| Diluted EPS | $6.25 | $6.93 | $7.78 | $9.63 | $6.82 |
Fiscal years, from SEC filings.
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
| SMA 10 | 115.7 | Bullish |
| EMA 10 | 116.5 | Bullish |
| SMA 20 | 114.6 | Bullish |
| EMA 20 | 115.7 | Bullish |
| SMA 50 | 116.4 | Bullish |
| EMA 50 | 116.4 | Bullish |
| SMA 100 | 118.1 | Bullish |
| EMA 100 | 116.5 | Bullish |
| SMA 200 | 114.5 | Bullish |
| EMA 200 | 114.5 | Bullish |
Oscillators (daily)
| RSI (14) | 66.74 | Neutral |
| MACD (12, 26) | 0.44 | Bullish |
| Momentum (12) | 7.33 | Bullish |
| Stochastic %K (14) | 93.44 | Bearish |
| Williams %R (14) | -6.56 | Bearish |
| CCI (20) | 177.8 | Bearish |
Pivot points (classic, last session)
S3 116.0 | S2 116.8 | S1 118.4 | Pivot 119.2 | R1 120.8 | R2 121.6 | R3 123.2 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.41 USD
Yield on today's price
2.01%
Frequency
Quarterly
Next ex-dividend date
Not announced
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | 0.6100 |
| 20 May 2026 | 0.6100 |
| 18 Feb 2026 | 0.6100 |
| 19 Nov 2025 | 0.5800 |
| 20 Aug 2025 | 0.5800 |
| 21 May 2025 | 0.5800 |
| 19 Feb 2025 | 0.5800 |
| 20 Nov 2024 | 0.5000 |
| 21 Aug 2024 | 0.5000 |
| 21 May 2024 | 0.5000 |
| 20 Feb 2024 | 0.5000 |
| 14 Nov 2023 | 0.4200 |
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
AFL SEC filings
7 Aug 2026
10-QSEC EDGAR
Quarterly report
6 Aug 2026
8-KSEC EDGAR
Results of operations; Regulation FD disclosure
30 Jun 2026
8-KSEC EDGAR
Other events
28 May 2026
8-KSEC EDGAR
Other events
18 May 2026
424B5SEC EDGAR
424B5
14 May 2026
8-KSEC EDGAR
Other events
11 May 2026
424B5SEC EDGAR
424B5
7 May 2026
8-KSEC EDGAR
Shareholder vote results
Where the numbers come from
Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.